KONVI
27.6.2024 09:01:30 CEST | Business Wire | Press release
Konvi, Europe’s leading luxury assets fractional investment platform, has announced the launch of a once-in-a-lifetime opportunity to invest in an exclusive Birkin bag designed by Alec Monopoly. This is a particularly exciting investment as it combines a piece of art by a prestigious artist with one of the best investment vehicles in the world – the Birkin bag – and the firm expects a high degree of interest from investors.
The value of a Birkin bag increases immediately upon leaving the store, leading many to say it’s a better investment than gold. Having never fluctuated downwards in value, Birkins are highly lucrative investments that consistently outperform the S&P 500 and boast double-digit annual returns.
Alec Monopoly rose to fame through his bright-coloured graffiti art and paintings which explore the themes of capitalism and luxury lifestyles. Birkin bags designed by Monopoly retail between an astounding $11,900 and $300,000. The famous handbags have also been sported by celebrities, including Khloe Kardashian, who owns a $25,000 piece painted by the artist.
Luxury assets are much more than a popular accessory, as they provide strong investment opportunities. The fact that returns on luxury items are negatively correlated with those on equities, bonds, and other collectible investments, makes them a great addition to an investment portfolio to ensure strong diversification.
Through Konvi’s app, investors can buy fractional shares of the luxury Birkin bag starting from €250 with immediate effect. Konvi buys and insures the asset and then sells it at the highest price, returning money to the asset's co-owners. This model enables users to access an extremely rare investment that would usually require significant capital and a broad network of collectors and auction houses to invest in.
Eran Peer, Co-Founder and CEO, commented: “Launching this exclusive luxury Alec Monopoly Birkin bag investment opportunity for Konvi users is central to our goal of bringing previously inaccessible luxury investment opportunities to a broader range of people. This offering means people can own a share in a bag adorned by some of the biggest celebrities on the planet, including the Kardashians, and reap the investment rewards. We’re excited to be bringing such a high-performing asset to our platform and look forward to launching similar investment opportunities in the near future.”
Investing in luxury assets such as art, fine wines, whiskeys, watches and vintage cars has long been inaccessible to the majority of people. High up-front costs, low availability and opaque, private markets with high fees mean historically only the most sophisticated investors and wealthy individuals could capitalise on these opportunities.
Konvi is the first Pan-European investment platform that enables retail investors to diversify their portfolios by fractionally investing in luxury assets. By collaborating with industry experts with strong track records, Konvi ensures that investment opportunities on its platform are carefully curated and accessible to everyone. Konvi also recently launched its latest Banksy art investment with one of the leading Banksy art piece curators, TGB Contemporary.
Visit Konvi’s website to find out how you can invest in this Alec Monopoly Birkin bag: https://konvi.app/en_GB/
About Konvi
Konvi is a pioneering online platform that democratises access to alternative investments, including hand-curated art, fine wine, classic cars, and more. With a user-friendly interface and innovative strategies, Konvi empowers individuals to build diversified portfolios and achieve their financial goals starting from an investment of €250.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240627487145/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom